Wednesday, October 26, 2022 10:54:18 AM
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
FDA Expands the Scope of the Company's Submission
Accelerates Path Toward Immunotherapy for Glioblastoma (Brain Cancer)
CLEVELAND, OH / ACCESSWIRE / October 26, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the approval of its application with the U.S. Food and Drug Administration (FDA) for Orphan Drug Designation (ODD) for TLR-AD1, a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas.
https://finance.yahoo.com/news/novaccess-global-receives-fda-approval-110000523.html
Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?
"We hope not." Richard Dennis
Recent XSNX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 08:06:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/27/2024 09:52:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 01:38:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/09/2024 05:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:47:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 06:44:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/18/2024 09:02:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:49:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 08:55:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 05:31:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 07:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 01:27:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 03:52:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:27:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 03:54:57 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM